Business Description
JSP Pharmaceutical Manufacturing (Thailand) PCL
ISIN : THA520010002
Compare
Compare
Traded in other countries / regions
JSP.Thailand IPO Date
2021-11-02Description
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name; Manufacture and distribution of hemodialysis solution and related medical supplies and Service, research and development, and healthcare products training. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.35 | |||||
| Debt-to-EBITDA | 2.32 | |||||
| Interest Coverage | 4.83 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.95 | |||||
| Beneish M-Score | -2.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.1 | |||||
| 3-Year EBITDA Growth Rate | 4.7 | |||||
| 3-Year Book Growth Rate | 62 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.3 | |||||
| 9-Day RSI | 30.65 | |||||
| 14-Day RSI | 37.3 | |||||
| 6-1 Month Momentum % | 0.89 | |||||
| 12-1 Month Momentum % | 8.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | |||||
| Quick Ratio | 0.81 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 83.73 | |||||
| Days Sales Outstanding | 47.16 | |||||
| Days Payable | 41.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.56 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| Forward Dividend Yield % | 3.13 | |||||
| 5-Year Yield-on-Cost % | 1.58 | |||||
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | -7.43 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.82 | |||||
| Operating Margin % | 10.84 | |||||
| Net Margin % | 6.89 | |||||
| FCF Margin % | 5.17 | |||||
| ROE % | 5.84 | |||||
| ROA % | 3.71 | |||||
| ROIC % | 5.01 | |||||
| ROC (Joel Greenblatt) % | 7.86 | |||||
| ROCE % | 6.57 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20 | |||||
| PE Ratio without NRI | 19.61 | |||||
| PS Ratio | 1.33 | |||||
| PB Ratio | 1.07 | |||||
| Price-to-Tangible-Book | 1.12 | |||||
| Price-to-Free-Cash-Flow | 24.05 | |||||
| Price-to-Operating-Cash-Flow | 8.21 | |||||
| EV-to-EBIT | 16.82 | |||||
| EV-to-EBITDA | 9.5 | |||||
| EV-to-Revenue | 1.73 | |||||
| EV-to-FCF | 33.43 | |||||
| Price-to-Graham-Number | 0.99 | |||||
| Earnings Yield (Greenblatt) % | 5.95 | |||||
| FCF Yield % | 4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JSP Pharmaceutical Manufacturing (Thailand) PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 742.258 | ||
| EPS (TTM) (฿) | 0.101 | ||
| Beta | 1.22 | ||
| Volatility % | 31.94 | ||
| 14-Day RSI | 37.3 | ||
| 14-Day ATR (฿) | 0.099935 | ||
| 20-Day SMA (฿) | 2.169 | ||
| 12-1 Month Momentum % | 8.65 | ||
| 52-Week Range (฿) | 1.88 - 3.02 | ||
| Shares Outstanding (Mil) | 474.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JSP Pharmaceutical Manufacturing (Thailand) PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JSP Pharmaceutical Manufacturing (Thailand) PCL Stock Events
| Event | Date | Price(฿) | ||
|---|---|---|---|---|
| No Event Data | ||||
JSP Pharmaceutical Manufacturing (Thailand) PCL Frequently Asked Questions
What is JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP)'s stock price today?
The current price of BKK:JSP is ฿2.04. The 52 week high of BKK:JSP is ฿3.02 and 52 week low is ฿1.88.
When is next earnings date of JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP)?
The next earnings date of JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP) is .
Does JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP) pay dividends? If so, how much?
The Dividend Yield %  of JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP) is 1.56% (As of Today), Highest Dividend Payout Ratio of JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP) was 0.31. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of JSP Pharmaceutical Manufacturing (Thailand) PCL(BKK:JSP) is 3.13%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers